Regulation & Compliance

A new partnership embeds PitchBook's data into Samaya AI, promising auditable insights for finance. Is this the answer to the AI 'black box' problem?

A new manufacturing patent for pelareorep de-risks Oncolytics' path to market, protecting the drug until 2044 and signaling commercial readiness.

Texas public agencies gain simplified access to critical cybersecurity through a new state contract with DirectDefense, facilitated by aggregator Carahsoft.

With the acquisition of an FDA-cleared app, UpRight Science is turning smartphones into medical devices to predict and prevent falls in older adults.

Fintech firm Hometap is betting its new pricing can make home equity investments a true rival to HELOCs, ditching monthly payments for a share of future value.

California homeowners face a new hurdle: insurers are requiring automatic water shut-off devices to combat costly leaks, reshaping risk in a post-wildfire era.

A small med-tech firm is betting its future on fingerprint sweat. Can its novel drug test pass the FDA's rigorous trials and disrupt a billion-dollar market?

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

A new partnership highlights how regulatory pressure and data analytics are forcing skilled nursing facilities to adopt tech for safer, more efficient patient care.

An award for Avalara from Chargebee highlights a critical shift: tax compliance is no longer a barrier but a strategic enabler for global growth.

A landmark ruling in Ouagadougou nullified a major gold deal, signaling a potent shift in power between global financiers and local African operators.

A new AI system at Nashville's airport promises shorter lines and better security. We analyze the tech and the execution challenges behind the hype.

A new free tool helps companies address menopause in the workplace, turning a source of silent talent drain into a powerful competitive advantage.

Geraci LLP, a top legal advisor, is betting its future on technology with a major platform launch in Miami. Is this the evolution of a multi-trillion dollar industry?

Verge Labs' new AI model promises to predict brain activity from a blood draw, potentially upending the costly and failure-prone world of neurology R&D.

Edgewise Therapeutics unveils strong Phase 2 data for its HCM drug, EDG-7500, showing efficacy without the cardiac risks plaguing market leaders.

A simple blood test for lung cancer completes key validation, signaling potential disruption for the diagnostics market and major savings for healthcare systems.

With a $240M user savings claim and top liquidity, MEXC's zero-fee model is a bold market play. But is it sustainable, and can its security promises hold up?

Onix launches its Wingspan platform in Europe, introducing proprietary 'Semantic Twin' technology to help regulated industries navigate the EU's strict AI compliance maze.

Enterprises have poured billions into data and AI, but many still struggle to turn insights into action. A new suite of tools aims to fix the disconnect.